Newer anti aids drugs are being marketed at up to 81 times the price of older anti Retrovirals that are being sold under an agreement to cut the cost of treatment in poor countries, the aid agency Medecins Sans Frontieres said.
Newer HIV aids drugs too expensive says Msf.